关注
Matteo Bovolenta
标题
引用次数
引用次数
年份
Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and mice
N Wein, A Vulin, MS Falzarano, CAK Szigyarto, B Maiti, A Findlay, ...
Nature medicine 20 (9), 992-1000, 2014
1302014
Cationic PMMA nanoparticles bind and deliver antisense oligoribonucleotides allowing restoration of dystrophin expression in the mdx mouse
P Rimessi, P Sabatelli, M Fabris, P Braghetta, E Bassi, P Spitali, G Vattemi, ...
Molecular Therapy 17 (5), 820-827, 2009
932009
Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype
S Brioschi, F Gualandi, C Scotton, A Armaroli, M Bovolenta, MS Falzarano, ...
BMC medical genetics 13, 1-15, 2012
852012
A novel custom high density-comparative genomic hybridization array detects common rearrangements as well as deep intronic mutations in dystrophinopathies
M Bovolenta, M Neri, S Fini, M Fabris, C Trabanelli, A Venturoli, E Martoni, ...
BMC genomics 9, 1-11, 2008
852008
Autosomal recessive Bethlem myopathy
F Gualandi, A Urciuolo, E Martoni, P Sabatelli, S Squarzoni, M Bovolenta, ...
Neurology 73 (22), 1883-1891, 2009
832009
Ex vivo COL7A1 correction for recessive dystrophic epidermolysis bullosa using CRISPR/Cas9 and homology-directed repair
A Izmiryan, C Ganier, M Bovolenta, A Schmitt, F Mavilio, A Hovnanian
Molecular Therapy-Nucleic Acids 12, 554-567, 2018
672018
Correction of the exon 2 duplication in DMD myoblasts by a single CRISPR/Cas9 system
A Lattanzi, S Duguez, A Moiani, A Izmiryan, E Barbon, S Martin, ...
Molecular Therapy-Nucleic Acids 7, 11-19, 2017
652017
The DMD locus harbours multiple long non-coding RNAs which orchestrate and control transcription of muscle dystrophin mRNA isoforms
M Bovolenta, D Erriquez, E Valli, S Brioschi, C Scotton, M Neri, ...
Public Library of Science 7 (9), e45328, 2012
582012
Exon skipping‐mediated dystrophin reading frame restoration for small mutations
P Spitali, P Rimessi, M Fabris, D Perrone, S Falzarano, M Bovolenta, ...
Human mutation 30 (11), 1527-1534, 2009
522009
Identification of a deep intronic mutation in the COL6A2 gene by a novel custom oligonucleotide CGH array designed to explore allelic and genetic heterogeneity in collagen VI …
M Bovolenta, M Neri, E Martoni, A Urciuolo, P Sabatelli, M Fabris, ...
BMC medical genetics 11, 1-12, 2010
372010
Identification and characterization of novel collagen VI non‐canonical splicing mutations causing ullrich congenital muscular dystrophy
E Martoni, A Urciuolo, P Sabatelli, M Fabris, M Bovolenta, M Neri, ...
Human mutation 30 (5), E662-E672, 2009
372009
Custom CGH array profiling of copy number variations (CNVs) on chromosome 6p21. 32 (HLA locus) in patients with venous malformations associated with multiple sclerosis
A Ferlini, M Bovolenta, M Neri, F Gualandi, A Balboni, A Yuryev, F Salvi, ...
BMC medical genetics 11, 1-10, 2010
332010
Antisense-induced messenger depletion corrects a COL6A2 dominant mutation in Ullrich myopathy
F Gualandi, E Manzati, P Sabatelli, C Passarelli, M Bovolenta, ...
Human gene therapy 23 (12), 1313-1318, 2012
322012
Rapid, comprehensive analysis of the dystrophin transcript by a custom micro‐fluidic exome array
M Bovolenta, C Scotton, MS Falzarano, F Gualandi, A Ferlini
Human Mutation 33 (3), 572-581, 2012
312012
Fo ATP synthase C subunit serum levels in patients with ST-segment Elevation Myocardial Infarction: Preliminary findings
G Campo, G Morciano, R Pavasini, M Bonora, L Sbano, S Biscaglia, ...
International Journal of Cardiology 221, 993-997, 2016
302016
Transcriptional behavior of DMD gene duplications in DMD/BMD males
F Gualandi, M Neri, M Bovolenta, E Martoni, P Rimessi, S Fini, P Spitali, ...
Human mutation 30 (2), E310-E319, 2009
272009
Deep RNA profiling identified CLOCK and molecular clock genes as pathophysiological signatures in collagen VI myopathy
C Scotton, M Bovolenta, E Schwartz, MS Falzarano, E Martoni, ...
Journal of cell science 129 (8), 1671-1684, 2016
242016
Exploring splicing-switching molecules for seckel syndrome therapy
D Scalet, D Balestra, S Rohban, M Bovolenta, D Perrone, F Bernardi, ...
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1863 (1), 15-20, 2017
232017
A naturally occurring mutation in ATP synthase subunit c is associated with increased damage following hypoxia/reoxygenation in STEMI patients
G Morciano, G Pedriali, M Bonora, R Pavasini, E Mikus, S Calvi, ...
Cell Reports 35 (2), 2021
222021
The absence of dystrophin brain isoform expression in healthy human heart ventricles explains the pathogenesis of 5'X-linked dilated cardiomyopathy
M Neri, E Valli, G Alfano, M Bovolenta, P Spitali, C Rapezzi, F Muntoni, ...
BMC Medical Genetics 13, 1-10, 2012
222012
系统目前无法执行此操作,请稍后再试。
文章 1–20